JJ Kiladjian, FF Marin, HK Al-Ali, A Alvarez-Larrán… - Annals of …, 2024 - Springer
Interferon-based therapies, such as ropeginterferon alfa-2b have emerged as promising
disease-modifying agents for myeloproliferative neoplasms (MPNs), including essential …